Literature DB >> 19826821

Lupoid sclerosis.

Briele Keiserman1, Luiz Fernando Garcias da Silva, Mauro W Keiserman, Carlos Alberto von Mühlen, Henrique Luiz Staub.   

Abstract

Lupoid sclerosis (LS) is a controversial entity, comprising features of both systemic lupus erythematosus and multiple sclerosis. Diagnostic criteria are a matter of debate, as well as the role of antinuclear and antiphospholipid antibodies. In this review, clinical and laboratory findings of LS available on Pubmed up to date are discussed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19826821     DOI： 10.1007/s00296-009-1175-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  59 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Recurrent longitudinal myelitis as primary manifestation of SLE.

Authors:  F-G Lehnhardt; P Impekoven; A Rubbert; L Burghaus; M Neveling; W-D Heiss; A H Jacobs
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

3.  Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren's syndrome.

Authors:  T Yamamoto; S Ito; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

4.  Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus.

Authors:  C Jacobi; K Stingele; R Kretz; M Hartmann; B Storch-Hagenlocher; A Breitbart; B Wildemann
Journal:  Lupus       Date:  2006       Impact factor: 2.911

5.  Multiple sclerosis and systemic lupus erythematosus in a 10-year-old girl.

Authors:  S Banerjee; L Kumar; S Singh; N Kakkar
Journal:  Indian Pediatr       Date:  1997-02       Impact factor: 1.411

6.  [Systemic lupus erythematosus and multiple sclerosis].

Authors:  G Rosati; G Serra; F Trotta; G Tralli; M Artioli
Journal:  Riv Neurobiol       Date:  1981 Jan-Mar

Review 7.  [Neurological manifestations of the antiphospholipid syndrome].

Authors:  Luisa Suárez Alvarez; Graham R V Hughes; Munther A Khamashta
Journal:  Med Clin (Barc)       Date:  2005-04-30       Impact factor: 1.725

8.  [A case of severe neuropsychiatric lupus erythematosus treated by plasmapheresis: diagnostic values of serum antiribosomal P protein antibodies and interleukin-6 in cerebrospinal fluid].

Authors:  W Fukui; H Sano; T Tanabe; T Ueda; S Hirohata; A Hashiramoto; R Yamada; H Kato; M Kondo
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  1998-08

9.  A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature.

Authors:  R S April; E Vansonnenberg
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

10.  Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.

Authors:  David P D'Cruz; Susana Mellor-Pita; Beatriz Joven; Giovanni Sanna; Judith Allanson; James Taylor; Munther A Khamashta; Graham R V Hughes
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666
View more
  4 in total

Review 1.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Heather Blackmore; George D Kitas
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

2.  Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus Cohort.

Authors:  Dionysis Nikolopoulos; Dimitrios Kitsos; Matilda Papathanasiou; Noemin Kapsala; Panagiotis Garantziotis; Antigone Pieta; Ourania Gioti; Alexandros Grivas; Konstantinos Voumvourakis; Dimitrios Boumpas; Antonis Fanouriakis
Journal:  Front Neurol       Date:  2022-05-11       Impact factor: 4.086

Review 3.  Neurological Disease in Lupus: Toward a Personalized Medicine Approach.

Authors:  Sarah McGlasson; Stewart Wiseman; Joanna Wardlaw; Neeraj Dhaun; David P J Hunt
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 8.786

Review 4.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy.

Authors:  Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.